Drug intelligence / Profile preview

quetiapine + vitamin B12

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral, Intramuscular
01

Overview

Quetiapine + vitamin B12 is a combination therapy involving quetiapine, an atypical antipsychotic, and vitamin B12 (cobalamin), a water-soluble vitamin essential for neurological function and hematopoiesis. Quetiapine acts primarily as an antagonist at serotonin 5-HT2A and dopamine D2 receptors, stabilizing mood and reducing psychotic symptoms in conditions such as schizophrenia, bipolar disorder, and major depressive disorder. Vitamin B12 is crucial for DNA synthesis, myelin formation, and cellular metabolism. In clinical studies involving patients with Alzheimer's disease (AD) experiencing psychosis or pain symptoms, the addition of vitamin B12 to quetiapine therapy resulted in improved psychiatric outcomes (notably on the Brief Psychiatric Rating Scale), reduced pain scores, modulation of pro- and anti-inflammatory cytokines (decreased IL-8/TNF-α; increased TGF-β), and enhanced cognitive measures compared to quetiapine alone[1][2][9]. This suggests that the combination may offer synergistic benefits in neuropsychiatric disorders where inflammation or neuropathic pain are present.

02

Targets

HRH1 (Histamine H1 Receptor)M1 (Muscarinic acetylcholine receptor M1)HTR2A (Serotonin receptor 5-HT2A)MTR (Methionine synthase)DRD2 (Dopamine D2 Receptor)ADRA1A (α1A)

Beyond the preview

Go deeper on quetiapine + vitamin B12.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on quetiapine + vitamin B12.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call